Yorktown Management & Research CO Inc Enanta Pharmaceuticals Inc Transaction History

Yorktown Management & Research CO Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 29, 2022	SELL	$56.06 - $74.11 $583,024 - $770,744	-10,400 Closed	0 $0
Q2 2021 Aug 03, 2021	BUY	$43.76 - $53.11 $258,184 - $313,349	5,900 Added 131.11%	10,400 $458,000
Q1 2021 May 11, 2021	BUY	$41.69 - $54.95 $187,605 - $247,275	4,500 New	4,500 $222,000
Q4 2020 Feb 11, 2021	SELL	$41.16 - $47.47 $185,219 - $213,615	-4,500 Closed	0 $0
Q1 2020 Apr 29, 2020	BUY	$40.22 - $62.0 $180,990 - $279,000	4,500 New	4,500 $231,000
Q3 2019 Nov 01, 2019	SELL	$60.08 - $88.17 $362,522 - $532,017	-6,034 Closed	0 $0
Q4 2018 Feb 08, 2019	BUY	$65.41 - $84.65 $23,416 - $30,304	358 Added 6.31%	6,034 $427,000
Q3 2018 Nov 08, 2018	BUY	$85.46 - $126.37 $40,935 - $60,531	479 Added 9.22%	5,676 $485,000
Q2 2018 Aug 10, 2018	BUY	$81.85 - $120.51 $425,374 - $626,290	5,197 New	5,197 $602,000

109

21.2M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $106M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Yorktown Management & Research CO Inc, based on Form 13F filings with the SEC.

Stay updated on Yorktown Management & Research CO Inc with notifications on news.